About Merieux Developement
Merieux Developement is a private equity firm founded in 2009. It is primarily based in Lyon, France. As of Oct 2026, Merieux Developement is an active investor with a portfolio of 11 companies, comprising 11 funding rounds and 2 acquisitions. In the last 12 months, it has participated in 1 funding round. The firm primarily invests in companies based in France and United States. Its portfolio is spread across a wide range of sectors from Life Sciences to High Tech. Its latest investment was a $***** Series D round in TISSIUM on Jun 24, 2026 along with Cathay Capital.
Overall Merieux Developement portfolio has seen 4 acquisitions, namely Quantalife, Seqens and Novacap. A lot of funds co-invest with Merieux Developement, with names like European Investment Bank sharing a substantial percentage of its portfolio.
Merieux Developement has a team of 13 people, including 8 partners.
Key Metrics
Founded Year
2009
Location
Lyon, France
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
Merieux Developement's Portfolio
Merieux Developement has a portfolio of 11 companies. They have invested in a total of 11 companies. Their most recent investment was in TISSIUM (Series D round) on Jun 24, 2026. Here are the most recent investments by Merieux Developement:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jun 24, 2026 | Series D | 9709 | ||
Nov 27, 2019 | Series D | 6931 | ||
May 24, 2019 | Series A | 1833 | ||
Jan 04, 2019 | Series C | 4930 |
Merieux Developement has acquired 2 companies. Their most recent acquisition was of Stiplastics on Jan 18, 2018. Here are the most recent acquisitions by Merieux Developement:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jan 18, 2018 | Plastic packaging solutions for pharmaceutical and medical device industries | - | 1985 | |
Jan 18, 2018 | Manufacturer of cardboard, folding boxes, transit packaging, and point-of-sale displays | - | 1879 |
Here is the portfolio snapshot of Merieux Developement:
Investments by Year
The maximum number of investments were made in 2019
Acquisitions by Year
The maximum number of acquisitions were made in 2018
Portfolio by Location
Companies are primarily in France and United States
Portfolio by Sector
Companies are primarily in Life Sciences
Team profile of Merieux Developement
Merieux Developement has a team of 13 members including 8 Partners located in France. Merieux Developement's team sits on the board of 1 company.Here is a list of top team members in Merieux Developement:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Lyon | - | ||
Partner | Lyon | - | ||
Partner | France | - | ||
Partner | Lyon | - | - | |
Partner | Lyon | - | - | |
Partner | Lyon | - | ||
Partner | Lyon | - | ||
Partner | Lyon | - | ||
Advisor | France | - | ||
Advisor | - | - | - | |
Associate | Paris | - |
Co-investors of Merieux Developement
Over the past 17 years, 10 investors have co-invested in Merieux Developement's portfolio companies.
- Top Co-investors of Merieux Developement: 10 investors entered a company along with Merieux Developement. These include investors like European Investment Bank (1 company).
Merieux Developement News
•
Inscripta Secures $125M in Series D FinancingFinSMEs•Dec 10, 2019•Inscripta, Paladin Capital, Venrock, Foresite and 7 others
•
Inscripta Receives Additional $20MMassinvestor•Apr 04, 2019•Inscripta, Venrock, Foresite Capital, Merieux Developement and 3 others
•
Mérieux Développement commits € 20 million into BiobestGlobeNewswire•May 03, 2018•Biobest Group, Merieux Developement
•
Xeris Pharmaceuticals, Inc. Completes $55 million In New Financing To Support Ready-To-Use Glucagon DevelopmentGlobeNewswire•Mar 08, 2018•Xeris Pharmaceuticals, Merieux Developement, Wild Basin Investments
•
Gene-editing startup Inscripta raises $55.5 millionReuters•Feb 28, 2018•Inscripta, Merieux Developement, Paladin Capital, Venrock and 5 others
•
Stage Capital to exit STI GroupPE Hub•Jan 18, 2018•STAGE CAPITAL LLP, Merieux Developement, Gimv, Sti-Group and 3 others
•
Mérieux Développement acquires a stake in Laboratoires Ineldea, in order to accelerate its commercial expansion in France and internationallyLifePulseHealth•Dec 14, 2017•INELDEA, Merieux Developement
•
Mérieux Développement Announces Equity Financing Into Xeris PharmaBioSpace•May 21, 2017•Xeris Pharmaceuticals, Merieux Developement, Bay City Capital, Redmile Group and 3 others
•
Xeris Pharmaceuticals Announces Closing of $30 Million FinancingEconoTimes•May 17, 2017•Xeris Pharmaceuticals, Merieux Developement, Bay City Capital, Redmile Group and 3 others
•
RA Capital Leads $25M Series C for IvantisCitybizlist•Jan 09, 2017•Ivantis, RA Capital Management, Ivantis, Merieux Developement